212 related articles for article (PubMed ID: 12914598)
21. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
[TBL] [Abstract][Full Text] [Related]
23. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of Photodynamic Therapy for Bowen's Disease Using Plum-Blossom Needling to Augment Drug Delivery.
Wu Y; Wang P; Zhang L; Wang B; Wang X
Dermatol Surg; 2018 Dec; 44(12):1516-1524. PubMed ID: 29994952
[TBL] [Abstract][Full Text] [Related]
25. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
[TBL] [Abstract][Full Text] [Related]
26. A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer.
Zeitouni NC; Paquette AD; Housel JP; Shi Y; Wilding GE; Foster TH; Henderson BW
Lasers Surg Med; 2013 Feb; 45(2):89-94. PubMed ID: 23390058
[TBL] [Abstract][Full Text] [Related]
27. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia.
Harth Y; Hirshowitz B; Kaplan B
Dermatol Surg; 1998 Jul; 24(7):723-6. PubMed ID: 9693665
[TBL] [Abstract][Full Text] [Related]
28. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview.
Cappugi P; Campolmi P; Mavilia L; Prignano F; Rossi R
J Chemother; 2001 Oct; 13(5):494-502. PubMed ID: 11760213
[TBL] [Abstract][Full Text] [Related]
29. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
30. [Topical photodynamic therapy in treatment of superficial skin tumors].
Szeimies RM; Landthaler M
Hautarzt; 1995 May; 46(5):315-8. PubMed ID: 7607894
[TBL] [Abstract][Full Text] [Related]
31. 5-Aminolevulinic acid-mediated photodynamic therapy to superficial malignant skin tumors using Super Lizer.
Hirata Y; Koga S; Fukui N; Yu A; Koshida S; Kosaka Y; Kurokawa T; Moriwaki S
J Dermatol; 2011 Aug; 38(8):748-54. PubMed ID: 21352331
[TBL] [Abstract][Full Text] [Related]
32. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
Fai D; Romano I; Fai C; Cassano N; Vena GA
G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
[TBL] [Abstract][Full Text] [Related]
33. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.
Lehmann P
Br J Dermatol; 2007 May; 156(5):793-801. PubMed ID: 17419691
[TBL] [Abstract][Full Text] [Related]
34. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
35. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.
Cairnduff F; Stringer MR; Hudson EJ; Ash DV; Brown SB
Br J Cancer; 1994 Mar; 69(3):605-8. PubMed ID: 8123497
[TBL] [Abstract][Full Text] [Related]
36. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy.
Morton CA; Whitehurst C; Moore JV; MacKie RM
Br J Dermatol; 2000 Oct; 143(4):767-72. PubMed ID: 11069454
[TBL] [Abstract][Full Text] [Related]
37. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
Morton CA
J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
[TBL] [Abstract][Full Text] [Related]
38. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
39. Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen's disease: a randomized intrapatient comparison between a continuous and a fractional ablative CO
Genouw E; Verheire B; Ongenae K; De Schepper S; Creytens D; Verhaeghe E; Boone B
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1897-1905. PubMed ID: 29633367
[TBL] [Abstract][Full Text] [Related]
40. Red light laser photodynamic therapy of Bowen's disease.
Parlette EC
J Drugs Dermatol; 2004; 3(6 Suppl):S22-4. PubMed ID: 15624738
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
